Iroko Pharmaceuticals Revenue and Competitors

Iroko Pharmaceuticals is an innovative, ethical pharmaceutical company that blends the best of two worlds: new ideas and a wealth of experience. Our mission is to help healthcare providers meet patient needs by focusing on providing proven, well-established, brand-name prescription products. Four of these trusted brands form the foundation of our business. The first three are Aggrastat ®(tirofiban HCL), Indocin® (indomethacin) and Aldomet ® (methyldopa), which were first introduced by Merck & Company, Inc. Iroko also markets Vancocin® (vancomycin hydrochloride) in Canada, which was launched there by Eli Lilly and Co. These products, as well as others we will select for Iroko Pharmaceuticals' brand enhancement and development, will benefit from a renewal of resources dedicated to improving and extending products to bring new value to patients and healthcare providers. Although our name may be new to you, our leadership capability is well honed. Iroko Pharmaceuticals is led by a senior management team of former top executives of some of the best-known major pharmaceutical companies. Each of us delivers deep expertise in all key aspects of the industry. We look forward to working with you.